Abstract:OBJECTIVE:To study the risk factors and clinical characteristics of post transplantation lymphoproliferative disorders (PTLD) after hematopoietic stem cell transplantation (HSCT).METHODS:Between August 2002 and October 2006, 585 patients underwent allogeneic HSCT (327 related matched donor, 208 mismatched family donor, 44 unrelated volunteer donor, 6 unrelated cord blood) at the Institute of Hematology in Peking University. PTLD was diagnosed on the basis of finding diffuse hyperplasia characterized by invasion of other organ structure with disorganization of the nodal structure in lymph nodes. If pathological investigation was not possible, PTLD was diagnosed by the presence of fever, lymph node enlargement and/or EBV viral load, which could not be explained by other causes. The incidence of PTLD was compared among different groups with chi2 test. Statistics was completed with PC by SPSS 13.0 Microsoft.RESULTS:The incidence of PTLD was 0.3% (1/327) in HLA matched related HSCT patients, 3.4% (7/208) in haploidentical HSCT patients and 2.3% in unrelated HSCT patients. The incidence of PTLD was higher in mismatched or unrelated HSCT group than that in conventional HSCT patients (7/208, 1/44,vs 0/323, P = 0.036). The incidence of PTLD is higher in patients with conditioning regimen including antithymocyte globulin (ATG) than that in patients without (9/262 vs 0/323, P = 0.005) (PTLD occurred in one patient who received reduced-intensity conditioning including ATG, but no PTLD occurred in conventional HSCT). 9 patients developed PTLD. 4 patients were diagnosed with pathology, the remaining 5 with clinical data. Onset of PTLD occurred at a median day of 43 (range 32450). 2 of them it occurred 6 months after HSCT and presented, with local mass and enlarged mediastinum. The morphology of biopsy appeared as small B-lymphocytic lymphoma; there was no response to chemotherapy and the patients died. In the remaining 7 patients it occurred an early stage after HSCT (day 32-78). 5 of them had a rapidly progressive course characterized by fever and lymphadenopathy, lung or liver or central nervous system involvement and died within weeks. One patient recovered by reducing immunosuppressive drug therapy combined with MP and one patient recovered by reducing immunosuppressive/antivirus therapy and donor lymphocyte infusion.CONCLUSIONS:Post HSCT PTLD occurs characteristically as disseminated disease with a rapidly progressive and often fulminant course and had a high mortality. It is essential to keep a vigilant eye on it especially in high risk patients.

Rare Co-occurrence of Spinal Cord Hemorrhage from Radiation-induced Cavernous Hemangioma and Classical Hodgkin Lymphoma Post-transplant Lymphoproliferative Disorder

Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation

High incidence of radiation-induced cavernous hemangioma in long-term survivors who underwent hematopoietic stem cell transplantation with radiation therapy during childhood or adolescence

Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases.

Coexistent Kaposi sarcoma and post-transplant lymphoproliferative disorder in the same lymph nodes after pediatric liver transplantation: A case report

Metachronous spinal cord involvement B cell and subcutaneous tissue involvement NK/T cell lymphoid proliferations and lymphomas arising in post-transplantation mimicking general NK/T cell lymphoma: a case report and review of the literature

A Case of Central Nervous System Post-Transplant Lymphoproliferative Disorder Following Haploidentical Stem Cell Transplantation in a Patient With Acute Lymphoblastic Leukemia

Intravascular large B-cell lymphoma as a covert trigger for hemophagocytic lymphohistiocytosis complicated with capillary leak syndrome: a case report and literature review

S4392 A Rare Case of T-cell Post-Transplant Lymphoproliferative Disorder (PTLD) Found Following a Diagnosis of Hemophagocytic Lymphohistiocytosis in a Patient With History of Liver Transplantation

Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disorder with Significantly Decreased T-cell Chimerism Early after Transplantation: A Case Report

Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report

Gastrointestinal Tract Post-Transplant Lymphoproliferative Disorder after Liver Transplantation

Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors and Association with CMV Reactivation and Graft-Versus-host Disease

A Rare Case of Systemic Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis in an Immunocompetent Young Man: Potential Diagnostic Pitfall and Therapeutic Challenge

Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysis

Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review

Epstein-Barr Virus–Related Post-Transplantation Lymphoproliferative Disorder after Unmanipulated Human Leukocyte Antigen Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical Outcomes

Risk Factors and Clinical Outcomes of Epstein–Barr Virus DNAemia and Post-Transplant Lymphoproliferative Disorders after Haploidentical and Matched-Sibling PBSCT in Patients with Hematologic Malignancies

Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease: A Case Report

Hemophagocytic Syndrome and Neurological Involvement in a Case of Intravascular Large B-cell Lymphoma.

[A Clinical Study of Lymphoproliferative Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation].